Search Tag: VA-ECMO
2024 02 Sep
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for treating cardiogenic shock and refractory cardiac arrest but involves significant risks and resource demands. It improves blood flow and oxygen content but often results in arterial hyperoxaemia. Although hyperoxaemia can be managed by adjusting the ECMO circuit...Read more
2019 20 Feb
Despite limited evidence, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for the management of refractory cardiogenic shock (RCS) while awaiting myocardial recovery or the bridge to long-term assistance or transplantation. However, despite technological advances and better quality of care, mortality still remains at...Read more
2019 16 Jan
Prediction scoring systems for coronary artery bypass grafting (CABG) patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) have not yet been reported. To help clinicians select patients that would benefit from VA-ECMO after CABG, a team of international researchers devised a mortality risk score – REMEMBER score – comprising...Read more